Epithelial Ovarian Tumors in Adolescents: A Retrospective Pathologic Study and a Critical Review of the Literature

Borderline ovarian tumor in adolescence: report of two cases and review of the literature

“…Adnexal torsion, as in the case of our two patients, is not a frequent manifestation. 2,10,11 With regard to the diagnosis of the nature of the tumor in the extemporaneous histology sample during surgery, its performance is varied. The agreement varies between 49.9% 11 and 78.6%.…”

Giant Ovarian Mucinous Cystadenoma in Premenarchal Girl

“…The incidence of epithelial tumors in childhood increases with age, and most occur in the period after menarche. The majority of [8,9]. Mucinous cystadenoma unilateral and benign [9] MCA tumors are extremely large, 76% are multilocular, and 24% are unilocular [2,3,10].…”

Adnexal Masses in Children and Adolescents

“…Like other ovarian pathology, these tumors are far more common in older women, but can also present in childhood and adolescence, representing 10% to 28% of ovarian tumors in these ages. 64,65 In a review of 23 patients, abdominal or pelvic pain (50%) and menstrual irregularities (12.5%) were the most common presenting symptoms, but 37.5% were asymptomatic at the time of diagnosis. 65 In a large series of 69 cystadenomas in children, 73% were serous, 24% mucinous, and 3% mixed serous/ .…”

“…64,65 In a review of 23 patients, abdominal or pelvic pain (50%) and menstrual irregularities (12.5%) were the most common presenting symptoms, but 37.5% were asymptomatic at the time of diagnosis. 65 In a large series of 69 cystadenomas in children, 73% were serous, 24% mucinous, and 3% mixed serous/ . At laparotomy a large right adnexal mass replaced the right ovary and a salpingoophorectomy was performed with a formal staging procedure.…”

“…Patients with FIGO stage II to IV disease have high rates of recurrent disease, 21% to 60%, and therefore require close monitoring for many years. 70,65,73 The role of adjuvant chemotherapy for stage II to IV borderline tumors is unclear. Higher recurrence rates are seen with adenocarcinoma, up to 75%, and therefore for patients with stage II and higher disease, fertility-preserving surgery is not currently recommended.…”